Agronomics Limited (AGNMF)

Overview

Agronomics Limited, founded on May 3, 2011, and based in Ramsey, Isle of Man, is a distinguished private equity and venture capital firm focusing on investments in emerging growth companies. Specializing in seed/startup, early venture, and growth capital investments, Agronomics Limited has established itself in the investment world by preferring to direct its funds towards the alternative proteins sector, particularly those involved in cellular agriculture, cultivated meat, and modern foods and materials technologies. Furthermore, the firm has broadened its investment horizon to include the biopharma sector, aiming to create a diversified portfolio across biotechnology and biopharmaceutical companies. Agronomics Limited's investment strategy is notable for its commitment to investing in both quoted and unquoted companies, making minority investments, and the prudent use of its balance sheet capital for investment purposes. Additionally, the company has shown flexibility in its investment approaches, such as considering investments in biopharma sector debt up to a certain limit and exploring various investment instruments to maximize returns and impact in the targeted sectors.

Products and Services

• Investment in Alternative Proteins: Agronomics Limited is keenly focused on investing in companies engaged in cellular agriculture and cultivated meat. The firm targets businesses developing the next generation of food products, aiming to revolutionize the food industry by making it more sustainable and ethical.
• Investment in Modern Foods and Materials Technologies: The firm looks to support nascent industries that are pioneering new materials and foods through innovative technologies. This includes a broad spectrum of companies, from those developing lab-grown materials to eco-friendly food alternatives, indicating a broad interest in sustainable and ethical innovation.
• Investment in Biopharma Sector: Agronomics expands its investment portfolio by focusing on the biopharma sector. This encompasses investments in biotechnology and biopharmaceutical companies developing groundbreaking medical treatments and health-related technologies. The firm's strategy includes making minority investments and possibly investing in biopharma sector debt, reflecting a comprehensive approach to fostering innovation in healthcare.
• Investments in Collective Investment Schemes and LEAPS: Agronomics Limited may also invest in shares of collective investment schemes that have exposure to the biopharma sector, which allows diversification of investment risks and returns. Furthermore, the firm considers long-term equity anticipation securities (LEAPS), particularly those based on biopharma sector securities or indices, as a way to hedge or leverage its investments in the biopharma sector over the long term.